Consultation

Home / Korea Market Entry

Device Classification & Regulatory Pathways

Medical devices are divided into Classes I through IV by risk, and the Korean pathway varies by class and category.

Class I commonly begins with a notification pathway, Class II with certification or approval review, and Classes III and IV with approval review. Product-specific characteristics and technical-document review requirements still need confirmation against current rules.

Classes and typical pathways

Typical pathways only; confirm product-specific exceptions and current rules.
ClassApplication pathway
INotification
IICertification or approval
IIIApproval
IVApproval

Source: MFDS approval process

Product information for classification

A practical review aid, not a complete statement of statutory duties, required submissions or contractual responsibilities. Confirm product-specific rules and agreements.
AreaPoints to confirm
Intended useExplain what the product diagnoses, treats or supports.
Operation and configurationDescribe its principle, components/materials, software and associated products.
EvidencePrepare the product description and any existing authorization information for comparison.

Frequently Asked Questions

What should we prepare for an initial discussion?

Product information, intended use, manufacturing details, approvals and available testing evidence.

When can timing be estimated?

After likely classification and material evidence gaps have been reviewed.

Reference basis

MFDS medical-device regulations · MFDS medical-device approval process · Content baseline · Check current requirements for the specific product

NEXT GUIDEDocumentation RequirementsPrepare product descriptions, safety and performance evidence, and manufacturing-site quality records as connected evidence sets.View next step
CONSULTATION

Clarify the Korean regulatory pathway for your product.

Attach what you have and we will reply by email after reviewing it. You do not need a complete set of documents.

Start a consultation
Device Classification & Regulatory Pathways | BCG